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We analyzed rest tremor, one of the etiologically most elusive hallmarks of Parkinson
disease (PD), in 12 consecutive PD patients during a speciﬁc task activating the locus
coeruleus (LC) to investigate a putative role of noradrenaline (NA) in tremor generation and
suppression. Clinicaldiagnosiswasconﬁrmedinallsubjectsbyreduceddopaminereuptake
transporter (DAT) binding values investigated by single photon computed tomography
imaging (SPECT) with [123I] N-ω-ﬂuoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) tropane
(FP-CIT). The intensity of tremor (i.e., the power of Electromyography [EMG] signals), but
not its frequency, signiﬁcantly increased during the task. In six subjects, tremor appeared
selectively during the task. In a second part of the study, we retrospectively reviewed
SPECT with FP-CIT data and conﬁrmed the lack of correlation between dopaminergic loss
and tremor by comparing DAT binding values of 82 PD subjects with bilateral tremor
(n = 27), unilateral tremor (n = 22), and no tremor (n = 33). This study suggests a role of
the LC in Parkinson tremor.
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INTRODUCTION
Tremor in Parkinson disease (PD) is characterized by 4–6Hz
activity at rest in the limbs with distal predominance. Despite its
clinical importance and the burden of morbidity associated with
it, the etiology of tremor is unknown, and its medical treatment
commonly ineffective.
The tremor in PD is remarkable for several features: (1) it is
neither a consistent nor a homogeneous feature across patients or
within an individual patient’s disease course; (2) it may diminish
in the end-stage of PD; (3) it occurs predominantly at rest and is
reduced or disappears by action; (4) it increases in amplitude or
can be triggered by maneuvers such as walking or psychological
statesasanxietyorstress(speciﬁctasks,likesimplearithmeticcal-
culation, may induce stress-related tremor) (Deuschl et al.,1998);
(5) it is not present during sleep; (6) it may be the predominant
or the only clinical sign for years before the appearance of aki-
nesia (Brooks et al., 1992); and (7) it poorly correlates with the
nigrostriatal dopaminergic deﬁcits (Isaias et al., 2007).
Although there is converging evidence of independent oscil-
lating circuits within a widespread “tremor-generating network”
(Mure et al., 2011), there is no conclusive explanation for the
onset of tremor in what it is fundamentally a hypokinetic move-
ment disorder.
Our hypothesis is that the locus coeruleus (LC) is involved in
the generation of tremor in PD. Preliminary evidence of a role
of adrenaline and noradrenaline (NA) in parkinsonian tremor
emerged from studies published in the 1960s and 1980s (Constas,
1962; Colpaert, 1987; Wilbur et al., 1988).
In this study we applied a speciﬁc and selective task activat-
ing the LC (Raizada and Poldrack, 2008), the main source of NA
in the brain, while recording tremor in 12 consecutive subjects
with PD.
In a second part of the study, we conﬁrmed retrospectively,
in a large and homogeneous cohort of PD subjects with and
without tremor, the lack of correlation between tremor and
dopaminergic innervation loss, investigated by means of sin-
gle photon computed tomography imaging (SPECT) with [123I]
N-ω-ﬂuoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) tropane
(FP-CIT) (Isaias et al., 2007).
MATERIALS AND METHODS
PATIENTS AND CLINICAL ASSESSMENT
The diagnosis of PD was made in all subjects according to the
UK Parkinson Disease BrainBank criteria andpatients were eval-
uated by means of the Uniﬁed Parkinson Disease Rating Scale
motor part (UPDRS-III). Two additional UPDRS subscores (i.e.,
a tremor subscore and an akinetic-rigid (AK) subscore) were also
calculated (Isaias et al., 2007). L-Dopa Equivalent Daily Doses
(LEDDs) were recorded as follows: 100mg levodopa = 1.5mg
pramipexole = 6mg ropinirole.
Clinical inclusion criteria were: (1) UPDRS part I and IV of 0;
(2) Hoehn andYahr(H&Y)stageof1or2in drugs-offstate atthe
time of SPECT (i.e., after overnight withdrawal of speciﬁc drugs
for PD; no patient was taking long-acting dopaminergic drugs);
(3) absence of any sign indicative for atypical parkinsonism (e.g.,
gaze abnormalities, autonomic dysfunction, and signiﬁcant psy-
chiatric disturbances) over a follow-up time of at least three
years after symptoms onset; (4) positive clinical improvement at
UPDRS after L-Dopa intake (i.e., >30% from drug-off state) at
some point during the three years of follow-up; (5) a normal
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Magnetic Resonance Imaging (MRI) (no sign of white matter
lesion or atrophy).
Additional inclusion criteria for the 12 consecutive patients
who took part to the prospective study were: (1) no other
disease other than PD; (2) no therapy change for the past
six months prior to the study; only patients with L-Dopa
or dopamine agonist were recruited and the uptake of any
drugs affecting the noradrenergic system (including, β-blockers,
MAO-B inhibitors, etc.,) was ruled out; (3) no cognitive decline
as well as no deﬁcit in visual attention. All subjects had normal
scores at the Mini-Mental State examination, the Clock Drawing
Test, the Frontal Assessment Battery, the Rey Auditory Verbal
LearningTest;theDigitSpanTest,andtheAttentive MatricesTest.
Depression was also ruled out by means of the Beck Depression
Inventory.
Fifteen healthy controls (four males, 11 female; 63 years
on average ±9 SD; range: 51–74 years) were prospectively
enrolled for comparisons of FP-CIT uptake. Healthy controls
were recruited from the general population (relatives of patients
were excluded) and, at the time of the study, did not suffer from
any disease and were not taking any medication.
The Local Ethics Committee approved the study and all sub-
jects gave their informed consent.
IMAGING
Dopamine-transporter (DAT) values were measured by means of
SPECT with [123I] FP-CIT.
SPECTdataacquisitionandreconstruction hasbeendescribed
in details elsewhere (Isaias et al., 2010). In brief, intravenous
administration of 110–140MBq of FP-CIT (DaTSCAN, GE-
Healthcare,UK) wasperformed 30–40minafter thyroid blockade
(10–15mg of Lugol oral solution) in subjects with PD subse-
quently overnight withdrawal of dopaminergic therapy and in
healthy controls. Brain SPECT was performed three hours later
by means of a dedicated triple detector gamma-camera (Prism
3000, Philips, Eindhoven, The Netherlands) equipped with low-
energy ultra-high resolution fan beam collimators (four sub-
sets of acquisitions, matrix size 128×128, radius of rotation
12.9–13.9cm, continuous rotation, angular sampling: 3degree,
duration: 28min). Brain sections were reconstructed with an
iterative algorithm Ordered Subsets Expectation Maximization
(OSEM, four iterations and 15 subsets) and then processed by
3D ﬁltering (Butterworth, order 5, cut-off 0.31 pixel-1) and
attenuation correction (Chang method, factor 0.12).
FP-CIT uptake values for the caudate nucleus and putamen of
both PD patients and healthy controls were calculated according
to Basal Ganglia Matching Tool (Calvini et al., 2007). The FP-CIT
uptake values in other brain regions were obtained with the cre-
ation, in the shapes menu of WFU Pick Atlas Tool, of speciﬁc
volumes of interest (VOIs).
Contralateral refers to the side opposite to tremor or to the
most affected side. For healthy controls we referred to the right
side as ipsilateral (Isaias et al., 2007).
AUDIO-VISUAL TASK AND EXPERIMENTAL DESIGN
We used the task of audio-visual simultaneity detection (A-V,
Raizada and Poldrack, 2008) in which subjects were presented
with a ﬂashed white disc and a burst of noise, their task being to
decidewhether thevisualandtheauditorystimuliwereperceived,
simultaneously or apart. A total of 50 visual and auditory stimuli
were presented, 10–15 of them, in random order, delivered apart.
The stimulus onset asynchrony between the visual and the audi-
tory stimuli was set at 200ms (A-V200), 100ms (A-V100)o r0m s
(A-Vnull) in three separate trials. The A-V200 task demonstrated
to speciﬁcally activate the LC-NA system. The A-V100 and the
A-Vnull task did not appear to elicit a brainstem response and
served as control tasks (Raizada and Poldrack, 2008). Inter-
stimuli time (i.e., the timebetween apaired audio-visualstimulus
and the following one) ranged randomly between 2.5 and 7s.
Each task was interpolated between a pre- (90s) and a post-task
period (up to epoch completion), with no audio-visual input.
Trials were randomized for all patients. At the beginning of the
experimental session, tremor activity was recorded for 60s at rest
and with no audio-visual input.
RECORDINGS
Muscle activity was registered with surface Electromyography
(EMG) electrodes placed on the extensor digitorum communis
(EDC), the ﬂexor digitorumcommunis(FDC), andthe opponens
pollicis (OP) muscles, bilaterally. To include only EMG bursting
activity, the EMG was high-pass ﬁltered off-line at 60Hz and rec-
tiﬁed (Timmermann et al., 2003). Recordings were performed
during rest and during the audio-visual task while the subjects
relaxed their arm and hand muscles. The examination was per-
formed at the same day-time (10:00h) for all patients. Patients
wereaskednottodrinkalcoholic,caffeine,orteafromtheevening
before the examination and they were off any medication in the
last three days before the task. The examination was performed
in a quiet room after allowing enough time for the patients to
become familiar with the surroundings.
GENERAL STATISTICAL ANALYSIS
Tremor frequency and intensity were compared by use of the
Wilcoxon signed-rank test for matched pairs. A pair was the same
individual butata different time duringthe task (e.g., pre-task vs.
task). Student’s t-test wasappliedto compareDAT bindingvalues
among patient sub-groups and healthy controls. Statistical analy-
ses were performed with the JMP statistical package,version 8.0.2
(SAS Institute, Inc., Cary, NC, USA).
RESULTS
Demographic and clinical features are listed in Table 1A for all
subjects with PD and further detailed in Table 1B for the 12
patients who performed the audio-visual tasks.
Table 2 lists DAT binding values. All 12 subjects enrolled for
the EMG recording showed a reduced DAT binding value in the
striatum (12% and 22% in the ipsilateral and contralateral cau-
date nucleus; 41% and 53% in the ipsilateral and contralateral
putamen), thus further conﬁrming the clinical diagnosis. DAT
binding values did not differ between PD subjects with and with-
out tremor in all regions investigated, also when weighted for
demographic (age at SPECT, age at onset, gender) and clinical
data (disease duration, disease severity, and LEDDs). Of interest,
DAT binding values in the pons (where the LC is located) resulted
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Table 1 | Clinical and demographic characteristics of the 82 subjects with PD (A) and of the 12 patients enrolled for the audio-visual task (B).
Table 1A
Bilateral tremor (n = 27; 21M) On-side tremor (n = 22; 16M) No tremor (n = 33; 22M)
Age at onset (years) 54 ± 11 58 ± 85 5 ± 8
Disease duration (years) 8 ± 55 ± 37 ± 5
UPDRS-III (0–108) score 23 ± 10 17 ± 7.41 8 .7 ± 9.7
UPDRS-tremor (0–28) score 5.2 ± 2.52 ± 0.80
UPDRS-AK (0–48) score 9.3 ± 56 .6 ± 3.51 0 .2 ± 6.6
LEDDs (mg) 424.6 ± 270 356.5 ± 256.1 506.0 ± 282.1
Table 1B
Patient Sex Age Disease H&Y UPDRS III—tremor UPDRS III—item 22 UPDRS III LEDDs (mg)
duration score left/right left/right (AK score) total score
1 M 64 18 2 3/2 2/2 (13) 28 560
2 M 73 10 2 3/0 2/2 (11) 27 510
3 M 56 10 2 2/0 1/0 (7) 20 710
4 M 70 5 2 0/2 1/2 (5) 12 580
5 F 71 4 2 0/2 2/1 (5) 13 610
6 M 73 4 2 3/0 2/0 (5) 19 300
7 M 58 12 2 3/1 2/2 (8) 16 210
8 M 70 4 2 3/0 2/0 (8) 24 480
9 M 69 9 2 0/3 2/2 (11) 23 400
10 F 76 3 2 3/1 2/2 (11) 22 300
11 M 69 6 2 2/0 2/2 (5) 12 255
12 M 65 7 2 0/1 2/2 (9) 18 450
Each patient’s disease severity was assessed using the Hoehn and Yahr (H&Y maximum is 5) stages and the Uniﬁed Parkinson Disease Rating Scale part III (UPDRS-
III; maximum score is 108). UPDRS item 20 and 21 refer to rest and action or postural tremor; item 22 refers to rigidity. UPDRS akinetic-rigid (AK) score was the sum
of items: 18 (speech), 19 (facial expression), 22 (rigidity), 27 (arising from chair), 28 (posture), 29 (gait), 30 (postural stability), 31 (body bradykinesia); tremor score
was the sum of items: 20 (tremor at rest), and 21 (action or postural tremor of hands). L-Dopa Equivalent Daily Doses (LEDDs) were recorded as follows: 100mg
levodopa = 1.5 mg pramipexole = 6mg ropinirole. In Table 1A, values are means ± SD. See text for inclusion criteria.
signiﬁcantlyhigherinPDpatients withtremor whencomparedto
healthy controls. Still, no difference was found between PD with
and without tremor within this region.
All 12 patients showed the typical parkinsonian rest tremor
in the frequency range of 4–6Hz. No changes in tremor fre-
quency or intensity were found during A-V100 and A-Vnull.O n
the contrary, tremor intensity greatly and consistently increased
during the A-V200 task in all patients (p < 0.001) (Table 3).
Interestingly, tremor frequency during the same task did not
signiﬁcantly change (Table 3,ﬁ r s tc o l u m n ) .T h eﬁ g u r ei l l u s -
trates tremor behavior in one patient during one trial with the
A-V200 task (n.4i nTable 3). Note that EMG activity of left EDC
(Figure1, mid box) appears only during the audio-visual task.
Interestingly, the power spectral analysis (Figure1,l o w e rb o x )
clearlydescribes,duringthe audio-visualtask,anenhancementof
tremor intensity and asustained 4.2Hz tremor frequency. Similar
results were found in all other PD subjects (Table 3).
DISCUSSION
The present study suggests a LC-related activity in the generation
of tremor in PD. We also conﬁrmed in an ample homogeneous
study population the lack of a correlation between dopaminergic
innervation loss and parkinsonian tremor (Isaias et al., 2007).
There is increasing evidence that resting tremor in PD is asso-
ciated with a distinct cerebello-thalamic circuitinvolving the ven-
tral intermediate nucleus of the thalamus (Vim), the cerebellum,
and the motor cortex. Indeed, a distinct ponto-thalamo-cortical
pattern, possibly involving the cerebellum/dentate nucleus, the
primary motor cortex, and the caudate/putamen have been iden-
tiﬁed in tremor-predominant PD patients (Mure et al., 2011).
More recently, a selective dopaminergic depletion of the globus
pallidus (but not striatum) has been reported to correlate with
clinical tremor severity and suggested to link the basal ganglia
with the cerebello-thalamic circuit in the onset of rest tremor
in PD (Helmich et al., 2011). We failed to ﬁnd any difference
of dopamine innervation loss (including the globus pallidus)
between PD subjects with bilateral, unilateral, or without tremor.
Indeed, structural lesions of the substantia nigra produceakinetic
syndromes but not tremor (Jenner and Marsden, 1984). The role
of the cerebellum has been also questioned by a multi-tracer PET
study showing that at least part of the cerebellar hyperactivation
seen in tremulous PD might be related to akinesia and rigidity
(Ghaemi et al., 2002). The development of rest tremor associated
with PD in a patient who had prior cerebellectomy further sug-
gested that the cerebellum is not the primary origin of tremor
(Deuschl et al., 1999).
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Table 2 | FP-CIT SPECT binding values.
Bilateral tremor One-side tremor No tremor Healthy controls
(n = 27) (right n = 11; left n = 11) (n = 33) (n = 15)
Frontal lobe 0.11±0.08 0.07±0.11 0.11±0.09 0.06±0.08
Cerebellum 0.12±0.07∗∗ 0.12±0.06∗∗ 0.11±0.09∗∗ 0.05±0.04
Pons 0.54±0.13∗ 0.53±0.11∗ 0.49±0.21 0.42±0.14
Brainstem 1.52±1.32 1.97 ±2.14∗∗ 1.85 ±1.48∗∗ 0.54±0.13
Midbrain 0.67±0.16 0.69±0.13 0.63±0.21 0.69±0.15
Thalamus contralateral 0.55±0.14 0.57±0.19 0.52±0.19 0.6±0.13
Thalamus ipsilateral 0.57±0.14 0.6±0.15 0.55±0.16 0.59±0.17
GPe contralateral 1.32±0.33∗∗ 1.31 ±0.26∗∗ 1.22 ±0.42∗∗ 2±0.32
GPe ipsilateral 1.32±0.39∗∗ 1.49 ±0.28∗∗ 1.3 ±0.42∗∗ 2.2±0.32
GPi contralateral 1.22±0.28∗∗ 1.21 ±0.24∗∗ 1.13 ±0.34∗∗ 1.6 ±0.33
GPi ipsilateral 1.21±0.32∗∗ 1.32 ±0.23∗∗ 1.19 ±0.33∗∗ 1.76 ±0.28
Caudate contralateral 3.14±1.02∗∗ 3.17±0.81∗∗ 3±0.94∗∗ 4.95±0.98
Caudate ipsilateral 3±0.89∗∗ 3.65±0.85∗∗ 3±0.97∗∗ 4.94±0.96
Putamen contralateral 2±0.73∗∗ 2±0.59∗∗ 2±0.86∗∗ 4.6±0.83
Putamen ipsilateral 2.17±0.75∗∗ 2.5±0.64∗∗ 2.22±0.87∗∗ 4.6±0.83
Data are shown as means ± SD (with the bilateral occipital cortex as reference region). Contralateral refers to the side opposite to tremor or to the most affected
side for patients without tremor. For healthy subjects, we conventionally referred to the right side as ipsilateral. For the one-side tremor group, the ipsilateral brain
regions refer to the hemisoma without rest or postural tremor. The absence of tremor (bilaterally or unilaterally) derived by a UPDRS-III score of 0 at the previous
visit (within two months) before SPECT and by the anamnestic statement by the patient of having not experienced tremor (bilaterally or at the non-tremor side).
FP-CIT uptake values for the caudate nucleus and putamen were calculated according to Basal Ganglia Matching Tool. The FP-CIT uptake values in other brain
regions were obtained with the creation, in the shapes menu of WFU Pick Atlas Tool, of speciﬁc volumes of interest (VOIs).
DAT binding values did not differ among PD sub-groups (with or without tremor), also when weighted for demographic (age at SPECT, age at onset, gender) and
clinical data (disease duration, disease severity, and LEDDs). Therefore, statistical signiﬁcance is marked only vs. healthy controls.
∗p = 0.01; ∗∗p < 0.001.
GPe = globus pallidus pars externa; GPi = globus pallidus pars interna.
Table 3 | Changes of tremor intensity (i.e., power of EMG signals) during the audio-visual task.
Patient Muscle fPEAK (fAVG) Pre-task (0–90s) A-V200 task (90s–EoT) Post-task early (EoT–400s) Post-task late (400–500s)
PPEAK (PAVG) PPEAK (PAVG) PPEAK (PAVG) PPEAK (PAVG)
1R - ﬂ e x 4 . 8 (4.6) 83 (50) 4250 (1118) 1975 (296) −
2R - ﬂ e x 4 . 9 (4.9) − 14,130 (1405) 9834 (2704) 1703 (376)
3L - e x t 5 . 8 (5.8) 380 (181) 1755 (912) 349 (260) 265 (70)
4L - e x t 4 . 2 ( 4.2) − 800 (296) 266 (100) −
5R - e x t 4 . 9 (5.1) 2686 (819) 8022 (2240) 3686 (501) −
6 L-opp 3.9 (3.9) − 14,759 (4286) −−
7L - ﬂ e x 4 . 9 (4.9) − 9563 (2937) 4314 (1552) −
8L - ﬂ e x 4 . 2 (4.2) − 7393 (838) −−
9 R-opp 4.3 (4.2) 1981 (719) 8806 (2963) 1222 (231) −
10 L-ext 5.5 (5.3) − 1244 (86) 145 (35) 109 (41)
11 L-opp 3.9 (3.9) − 2907 (267) −−
12 R-opp 3.5 (3.5) − 135 (56) −−
Pre-task refers to a period of 90s without stimuli preceding the audio-visual task (A-V200). Post-task early refers to the ﬁrst time period without stimuli after the task
end (from End-of-Task (EoT) to 400 s counting from the start of the EMG recording); post-task late refers to the last part of the period without stimuli (from 400 to
the end of EMG recording). We listed only the activity of the most-affected muscle. Tremor frequency, when tremor was present, did not change throughout the
task. The intensity of tremor signiﬁcantly increased during the task in all subjects.
fPEAK = peak frequency; fAVG = average frequency; PPEAK = tremor power peak; PAVG = tremor power average; “–“ refers to absence of tremor activity at EMG.
Note that given the randomized presentation of the visual and auditory stimuli, the EoT time differed among subjects (ranging from 127 to 198s).
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FIGURE 1 | Tremor behavior during the audio-visual (A-V200)t a s ki n
one patient. Upper box: Audio-visual task (A-V200 task). Red lines indicate
when ﬂashed white disk and noise were not simultaneous, blue lines when
they were simultaneous. The stimulus onset asynchrony between the
visual and the auditory stimuli was set at 200ms (visual preceding
auditory). A total of 50 visual and auditory stimuli were presented. Space
between lines indicate time interval (ranging between 2.5 and 7s). Mid
box: EMG recordings (in blue), high-pass ﬁltered off-line at 60Hz and
rectiﬁed. Single vertical lines (in black) show the start and end of the A-V200
task, respectively. Lower box: Spectral analysis of tremor activity showing a
sustained tremor frequency at 4.2Hz. The harmonic double tremor
frequency is also clearly represented. The power of EMG signals (intensity
of tremor) is shown in colors (right column scale).
The LC is a cluster of NA-containing neurons located in the
upper dorsolateralpontinetegmentum. LC neurons ﬁreinatonic
or phasic mode (Aston-Jones and Cohen, 2005). Tonic activity is
characterized by sustained and highly regular discharge pattern
that is highest during wakefulness, decreases during slow-wave
sleep, and virtually ceases during Rapid Eye Movement (REM)
sleep. LC phasic mode involves activation of LC neurons follow-
ing task-relevant processes in response to environmental stimuli
that elicit behavioral arousal and exploratory behavior (Aston-
Jones and Cohen, 2005). Animal studies reported that neurons
in the LC can show also a synchronous activity. Synchronous
oscillations would rely on electronic coupling and are seem-
ingly independent of synaptic transmission. Electrotonic cou-
pling between LC neurons could serve to facilitate synchrony
in the event of a large afferent input (Ishimatsu and Williams,
1996).
LC neurons have extensively branched axons that project
throughout the neuraxis and provide the sole source of NA
to the neocortex, cerebellum, and most of the thalamus (Aston-
Jones and Cohen, 2005), all possibly involved in tremor onset. In
particular, the release of NA from LC axons causes inhibition of
ongoing purkinje cell activity, thus facilitating one or more func-
tions ofregions underpurkinje inhibitory control. Noradrenergic
input to the thalamic cells promotes a single spike-ﬁring mode
of activity in the thalamus that has been related to increased
cortical activity and responsiveness. The LC also innervates
extensively and it is the sole source of cortical NA. It is likely
that this noradrenergic input to the neocortex is excitatory
and contributes to the generally recognized role of the LC as
a major wakefulness-promoting nucleus (Samuels and Szabadi,
2008a,b).
The biochemistry of NA neurons has great relevance to PD
(Delaville et al., 2011; Isaias et al., 2011). Of note, in the
normal condition, dopamine β-hydroxylase synthesizes NA from
dopamine. The LC-NA system modulates the survival of its tar-
get neuronal populations, which include dopaminergic neurons
in the substantia nigra (Mavridis et al., 1991; Frey et al., 1997;
Rommelfanger andWeinshenker, 2007). The LC mayalsodirectly
inﬂuence the activity of the nigrostriatal dopaminergic system.
Single-cell recording studies demonstrated a noradrenergic mod-
ulation ofmidbraindopamineneuronalactivity consistent with a
direct pathway from the LC to the substantia nigra. In particular,
injections of the adrenergic neurotoxin N-(2-Chloroethyl)-N-
ethyl-2 bromo benzylamine hydrochloride (DSP-4) in the ventral
tegmental area or direct lesioning of the LC by local injec-
tion of 6-hydroxy-dopamine (6-OHDA) resulted in a signiﬁcant
decrease in the basal release of dopamine in the caudate nucleus
(Collingridge et al., 1979; Lategan et al., 1992), and result in the
compensatory up-regulation ofstriatal D2 receptors (Harroet al.,
2003). NA facilitates burst ﬁring of substantia nigra pars com-
pacta, while administration of the α1-adrenoceptor antagonist
prazosin attenuates ﬁring (Grenhoff and Swensson, 1993).
The LC is thought to degenerate in PD as part of the dis-
ease pathology (Braak et al., 2003). Still, Lewy pathology poorly
correlates with neuronal loss in speciﬁc areas, thus its predic-
tive validity for neuronal disintegration is questionable (Jellinger,
2009). Moreover, noradrenergic neurons in the LC are relatively
preserved in early PD (Isaias et al., 2011; Pavese et al., 2011)a n d
do not exhibit the same intracellular changes as in the substan-
tia nigra (Halliday et al., 2005). Finally, the LC may degenerate
onlyin speciﬁc PDpatients (Cash etal., 1987). Ofinterest, animal
studies showed a signiﬁcantly increased activity of noradrenergic
neurons in LC after unilateral lesion of the nigrostriatal pathway
(Wang et al., 2009).
Mevawalla and colleagues (Mevawalla et al., 2009)r e p o r t e da
case of unilateral rest tremor in a patient with vascular parkin-
sonism and contralateral lesion of the LC. The Authors suggest
that the unilateral LC lesion contributed to the pathogenesis
of contralateral tremor. There are several concerns related to
this clinical case that prevent any ﬁrm conclusion. The patient
suffered from vascular parkinsonism and macroscopically pre-
sented vascular lesions in the globus pallidus bilaterally, right
p u t a m e na n di n t e r n a lc a p s u l e .T h ep r e s e n c eo ft o n g u et r e m o r
supports a cerebellar involvement, which was not investigated
by the Authors. Moreover, no functional studies have been car-
ried out in vivo, nor functional staining (e.g., TH-staining) in
ex vivo specimina. Last but not least, the LC projects almost
exclusively ipsilaterally and, therefore, the tremor would relate to
the intact LC rather than the lesioned one. This would eventu-
ally support, rather than confute our hypothesis. Still, based on
our preliminary results, we cannot exclude that tremor in PD
derives from a paradoxical effect of NA and dopamine depletion
(Dzirasa et al., 2010).
The main limitation of this study relates to poor speciﬁcity
of the A-V200 task. Still, this task proved to selectively activate
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the brainstem in an in vivo imaging study (Raizada and Poldrack,
2008). We also did not ﬁnd changes in tremor activity during
A-V100 and A-Vnull trials, both tasks being not able to elicit an
activation of brainstem but of other brain areas (i.e., frontal
region) (Raizada and Poldrack, 2008).
Secondly, the LC-NA system and the noradrenaline molec-
ular transporters (NET) should be ideally investigated in vivo
by dedicated, highly speciﬁc radiotracers displaying low back-
ground non-NET binding, high sensitivity to variations in NET
density, and fast kinetics. As such, a radiotracer is not avail-
able for large clinical studies, we retrospectively collected data
of SPECT with FP-CIT in a large, homogeneous cohort of
PD patients out of our database (Centro per la Malattia di
Parkinson e i Disturbi del Movimento, Milano). Although FP-
CIT is mainly used for assessing striatal dopamine reuptake
transporters (DATs), it has shown some, albeit lower, sensitiv-
ity, to NET (Booij and Kemp, 2008). Hence, when applied to
an anatomical region with known low DAT capacity such as the
LC, it allows investigation on the NA-dependent synaptic activ-
ity (Isaias et al., 2011). In the brainstem, no other anatomical
region, beside the LC, show clearly detectable density of NET
(nor DAT).
Studying the LC can be challenging to say the least. In partic-
ular, (1) directly recording in humans the activity of LC is not
applicablegiven its anatomicalstructure andlocation;(2) the size
of LC is atthe spatialresolution limits of currently availableimag-
ing techniques; and (3) even receptor binding (or displacement)
studies and PET might not catch its phasic electrical activity.
A n y h o w ,a l o n go u rr e s u l t s ,i ti st e m p t i n gt oh y p o t h e s i z ea na c t i v e
role of the LC-NA system in triggering tremor onset in PD. While
the frequency of parkinsonian tremor might be related to the
intrinsic oscillating properties of dopamine depleted circuits, the
onset and intensity of tremor might relate to the activity of the LC
and of its noradrenergic output.
The introduction of the LC in the neural network dynamics
of parkinsonian tremor might well explain many of its remark-
able features. In particular, (1) tremor would appear only in PD
subject with no functional damages of the LC; (2) eventually,
along with PD progression and a consequent degeneration of LC-
NA system, tremor will diminish; (3) tremor will appear during
maneuvers that trigger LC activity, above all stress; and (4) PD
patients do not manifest tremor during sleep being the LC silent.
Finally, given a putative neuroprotective and compensatory activ-
ity ofLC-NAonitstarget cells(includingthe substantianigraand
the striatum), it is tempting to speculate that an intact, or hyper-
active, LC-NA system might be responsible for a more benign
progression of PD in patients with tremor.
In conclusion, parkinsonian tremor would be the outcome of
subtle derangements in the ﬁnely tuned NA-DA interplay, where
the dopaminergic failure would involve complex noradrenergic
adjustments leading to motor anomalies in the presence of an
intact LC, which might be onlyanecessary state butnotthe direct
cause of rest tremor in PD.
All these pending questions obviously require further stud-
ies in the future both by imaging and laboratory techniques. On
this track, we hypothesize that parkinsonian tremor might rep-
resent the clinical sign of an enhanced LC activity as possible
compensatory process over dopaminergic loss.
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